MolNFT v1 · #47216 · protein
Human thymidine kinase 1 in complex with TP4A
2ORV: “Human thymidine kinase 1 in complex with TP4A”. X-ray diffraction, 2 ligands (4TA, ZN), 4 pockets (best druggability 0.64). MolNFT v1 #47216 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2ORV
- Type
- protein
- Length
- 323 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Thymidine kinase
- EC
- 2.7.1.21
- UniProt
- P04183
- Ligands
- 4TA, ZN
- Pockets
- 4 · best druggability 0.64
Structure
x-ray diffraction · 2 distinct chains · 28% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Thymidine kinase (EC 2.7.1.21) | protein | 163 | 28% helix, 27% strand | P04183 |
| B | Thymidine kinase (EC 2.7.1.21) | protein | 160 | 28% helix, 28% strand | P04183 |
Ligands and binding sites
- 4TA · P1-(5'-adenosyl)p4-(5'-(2'-deoxy-thymidyl))tetraphosphate · ligand · 2 copies · chains A, B
- ZN · Zinc ion · metal · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 173 | 0.64 | 0.85 | 32 | 4TA |
| 2 | 122 | 0.61 | 0.86 | 28 | 4TA |
| 3 | 104 | 0.39 | 0.76 | 17 | empty |
| 4 | 71 | 0.37 | 0.78 | 18 | empty |
Interfaces
1 interface between chains.
- A–B · 1245 Ų buried · 32 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P04183
- Elsewhere: RCSB PDB 2ORV · PDBe 2ORV · UniProt P04183
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.